The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia
Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Autoimmune thrombocytopenic purpura is an immunological disorder characterized by increased
platelet destruction due to presence of anti-platelet antibodies. Hepatitis C virus
infection, which is one of the most common chronic viral infections worldwide, may cause
secondary chronic immune thrombocytopenic purpura. It seemed to play a pathogenic role in
autoimmune thrombocytopenic purpura. Moreover, the successful response (negative hepatitis C
virus - ribonucleic acid) to tapered steroids and antiviral therapy was useful to revert
thrombocytopenia
Phase:
N/A
Details
Lead Sponsor:
Assiut University
Treatments:
Antiviral Agents Ledipasvir Ledipasvir, sofosbuvir drug combination Sofosbuvir